Global Cell Based Cartilage Repair/Regeneration Market Size, Trends and Insights By Therapy Type (Autologous Cell Therapy, Allogeneic Cell Therapy, Others), By Mode of Administration (Intra-articular Injection, Scaffold Implantation, Surgical Implantation), By End Users (Hospitals and Clinics, Research Institutions and Biotechnology, Pharmaceutical Companies), and By Region -  Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2023–2032


Report Code: CMI27472

Published Date: August 2023

Pages: 220+

Category: Healthcare

Report Snapshot

CAGR: 5.3%
675.4M
2022
706.1M
2023
981.7M
2032

Source: CMI

Study Period: 2023-2032
Fastest Growing Market: Asia-Pacific
Largest Market: Europe

Major Players

  • Vericel Corporation
  • Osiris Therapeutics Inc. (now part of Smith & Nephew)
  • Zimmer Biomet Holdings Inc.
  • Anika Therapeutics Inc.
  • Others

Exclusive, in-depth market intelligence can help you increase your Revenue.

Download Sample Pdf

Reports Description

As per the current market research conducted by CMI Team, the global Cell Based Cartilage Repair/Regeneration Market is expected to record a CAGR of 5.3% from 2023 to 2032. In 2022, the market size is projected to reach a valuation of USD 675.4 million. By 2032, the valuation is anticipated to reach USD 981.7 million.

Cell Based Cartilage Repair/Regeneration Specification

Specification
 Cell type  Autologous chondrocytes  Allogeneic cells
 Delivery method  Autologous chondrocyte implantation (ACI)  Intravenous infusion
 Indication  Repair of full-thickness cartilage defects  A variety of conditions, including cancer, autoimmune diseases, and heart disease
 Success rate  70-80%  Varies depending on the condition
 Recovery time  6-12 months  Varies depending on the condition
 Risks  Infection, bleeding, pain, stiffness  Graft-versus-host disease (GvHD), infection, and toxicity
 Cost  $10,000-20,000 (Approx)  Varies depending on the condition
Source: According to CMI Market Research Team Analysis

 The Cell-Based Cartilage Repair/Regeneration Market involves developing and selling therapies that use cells to repair damaged cartilage, helping people with conditions like osteoarthritis and sports injuries. It’s a dynamic market driven by advancements in regenerative medicine.

Companies, researchers, and healthcare providers work together to create innovative treatments using stem cells, tissue engineering, and bioprocessing. Trends include personalized medicine, digital health solutions for patient monitoring, and more investment in research by biotech companies and governments. There’s also a focus on less invasive treatments and exploring new applications for cell-based therapies.

Cell Based Cartilage Repair/Regeneration Market – Significant Growth Factors

The Cell Based Cartilage Repair/Regeneration Market presents significant growth opportunities due to several factors:

  • Growing Aging Population: The global aging population has resulted in a higher prevalence of cartilage disorders. As people age, the natural regenerative capacity of cartilage diminishes, making the elderly more susceptible to cartilage injuries and degeneration. This demographic trend has created a substantial market for cell-based cartilage repair solutions.
  • Personalized Medicine: The trend towards personalized medicine presents an opportunity for tailored cell-based therapies. With advancements in cell characterization and patient-specific treatments, personalized regenerative approaches can provide more effective and targeted outcomes, driving further demand in the market.
  • Integration of Digital Health Solutions: The adoption of digital health solutions, such as remote monitoring devices and wearable technology, offers opportunities for enhancing patient care and post-treatment follow-up. The integration of these technologies can improve treatment outcomes, patient compliance, and overall patient experience in cell-based cartilage repair/regeneration.
  • Expanding Application Areas: Researchers and clinicians are exploring the potential of cell-based therapies beyond osteoarthritis and sports injuries. Diversifying application areas to address cartilage defects caused by trauma, congenital disorders, and other joint-related conditions can open up new opportunities and widen the market scope for cell-based cartilage repair/regeneration therapies.
  • Regulatory Support and Approvals: Supportive regulatory frameworks and streamlined approval processes for regenerative medicine products can create opportunities for companies to bring their cell-based cartilage repair/regeneration therapies to market faster. Clear guidelines and faster approvals encourage investment and research in this field, driving market growth.
  • Public Awareness and Education: Increasing public awareness about the benefits and potential of cell-based cartilage repair/regeneration therapies is crucial for market expansion. Education campaigns and awareness programs can help patients and healthcare professionals understand the advantages of these treatments, leading to higher acceptance and adoption rates.

Cell Based Cartilage Repair/Regeneration Market – Mergers and Acquisitions

The Cell Based Cartilage Repair/Regeneration Market has seen several mergers and acquisitions in recent years, with companies seeking to expand their market presence and leverage synergies to improve their product offerings and profitability. Some notable examples of mergers and acquisitions in the Cell Based Cartilage Repair/Regeneration Market include:

  • Zimmer Biomet and Axiomed (2019): In 2019, Zimmer Biomet, a global leader in musculoskeletal healthcare, entered into a partnership with Axiomed, a medical technology company. The collaboration aimed to combine Axiomed’s innovative nucleus replacement technology with Zimmer Biomet’s cell-based regenerative therapies, providing a comprehensive solution for patients with degenerative disc disease and related cartilage issues.
  • CollPlant Biotechnologies and United Therapeutics (2020): CollPlant Biotechnologies, a regenerative medicine company, teamed up with United Therapeutics, a biotechnology firm, to advance a 3D bioprinting technology for cartilage repair. This collaboration focused on developing advanced scaffolds using CollPlant’s plant-based rhCollagen and integrating United Therapeutics’ expertise in regenerative medicine, paving the way for personalized cartilage treatments.
  • Smith & Nephew’s Acquisition of Osiris Therapeutics (2019): Smith & Nephew, a global medical technology company, acquired Osiris Therapeutics in 2019. This strategic acquisition allowed Smith & Nephew to expand its regenerative medicine portfolio with Osiris Therapeutics’ innovative cell-based products, including those for cartilage repair and wound healing.
  • Ocugen, Inc.’s Acquisition of Histogenics Corporation (2020): In 2020, Ocugen, Inc., a biopharmaceutical company, acquired Histogenics Corporation, which was focused on regenerative medicine. This acquisition enabled Ocugen to gain access to Histogenics’ NeoCart, an autologous cell-based therapy for cartilage repair, strengthening Ocugen’s position in the cell-based cartilage repair/regeneration market.

These mergers and acquisitions have helped companies expand their product offerings, improve their market presence, and capitalize on growth opportunities in the Cell Based Cartilage Repair/Regeneration Market. The trend is expected to continue as companies seek to gain a competitive edge in the market.

COMPARATIVE ANALYSIS OF THE RELATED MARKET

Cell Based Cartilage Repair/Regeneration Market Cartilage Repair/Regeneration Market Gen Z Mental Health Market
CAGR 5.3% (Approx) CAGR 15% (Approx) CAGR 9.2% (Approx)
USD 981.7 Million by 2032 USD 2.32 Billion by 2030 USD 75.6 Billion by 2032

Cell Based Cartilage Repair/Regeneration Market – Significant Threats

The Cell Based Cartilage Repair/Regeneration Market faces several significant threats that could impact its growth and profitability in the future. Some of these threats include:

  • Regulatory Challenges and Approval Delays: The complex regulatory landscape and lengthy approval processes for regenerative medicine products can pose a significant threat to companies in the cell-based cartilage repair/regeneration market. Delays in obtaining regulatory approvals may hinder the timely launch of new therapies, impacting market growth and competitiveness.
  • High Development and Manufacturing Costs: Developing and manufacturing cell-based therapies involve substantial costs, including research, clinical trials, and specialized facilities. High upfront investment can deter smaller companies from entering the market, limiting competition and potentially leading to higher product prices.
  • Competition from Traditional Treatments and Alternatives: Established traditional treatments, such as pain management and surgical interventions, and alternative therapies may continue to compete with cell-based cartilage repair/regeneration treatments. The availability of less expensive or more accessible options can impact the demand for cell-based therapies in the market.
  • Limited Reimbursement Policies: Inadequate or restrictive reimbursement policies for cell-based cartilage repair/regeneration therapies can be a significant barrier to patient access. If these treatments are not adequately covered by insurance or healthcare systems, it may deter patients from opting for these innovative therapies, impacting the market demand and revenue potential.

Report Scope

Feature of the Report Details
Market Size in 2023 USD 706.1 Million
Projected Market Size in 2032 USD 981.7 Million
Market Size in 2022 USD 675.4 Million
CAGR Growth Rate 5.3% CAGR
Base Year 2022
Forecast Period 2023-2032
Key Segment By Therapy Type, Mode of Administration, End Users and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

Category-Wise Insights

By Therapy Type:

  • Autologous Cell Therapy: In cell-based cartilage repair/regeneration, autologous cell therapy involves harvesting a patient’s own cells, processing them, and re-implanting them into the damaged cartilage area. This personalized approach aims to stimulate cartilage regeneration, leveraging the patient’s natural healing capabilities. The trend toward personalized medicine drives the growing adoption of autologous cell therapy in the market.
  • Allogeneic Cell Therapy: Allogeneic cell therapy utilizes cells from a donor, which are processed and then administered to the recipient for cartilage repair/regeneration. This approach offers the advantage of off-the-shelf availability, reducing the need for cell harvesting from the patient. Increasing research in allogeneic cell sources and advanced tissue engineering techniques are driving trends in this segment.
  • Others: The other segment includes Induced Pluripotent Stem Cells (iPSCs) and Embryonic Stem Cells (ESCs). IPSCs are reprogrammed adult cells with embryonic stem cell-like properties. Moreover, Embryonic Stem Cells (ESCs)are derived from early-stage embryos and have the ability to differentiate into various cell types, including chondrocytes.

Cell Based Cartilage Repair/Regeneration Market 2023–2032 (By Million)

www.custommarketinsight.com

By Mode of Administration

  • Intra-articular Injection: Involves directly injecting cell-based therapies into the affected joint or cartilage area using minimally invasive techniques, promoting targeted and localized repair. The market trend shows an increasing preference for less invasive treatments, making intra-articular injections a popular mode of administration for cartilage repair/regeneration therapies.
  • Scaffold Implantation: This approach combines cell-based therapies with a biocompatible scaffold, providing structural support and aiding in cartilage regeneration. The market trend indicates a growing focus on tissue engineering and scaffold technologies, enhancing the efficiency and success rates of cartilage repair/regeneration treatments.
  • Surgical Implantation: In more severe cases, surgical procedures are employed to implant cell-based therapies along with additional cartilage repair techniques. The market trend shows the continuous exploration of advanced surgical methods and a push for improved outcomes in cases requiring extensive cartilage repair/regeneration interventions.

End Users

  • Hospitals and Clinics: Hospitals and clinics are important users in the Cell-Based Cartilage Repair/Regeneration Market. They provide patients with access to advanced cell-based therapies for cartilage disorders. These treatments use the latest regenerative medicine and bioprocessing techniques, offering effective and long-lasting solutions for patients’ cartilage problems.
  • Research Institutions and Biotechnology Companies: Research institutions and biotechnology companies are key drivers of advancements in the Cell-Based Cartilage Repair/Regeneration Market. They actively conduct research and clinical trials to develop cutting-edge regenerative solutions. Collaborative efforts between researchers and biotech firms facilitate the exploration of new cell sources, tissue engineering techniques, and manufacturing processes, contributing to the continuous evolution of therapies for cartilage repair and regeneration.
  • Pharmaceutical Companies: These companies drive the Cell-Based Cartilage Repair/Regeneration Market by developing and selling cell-based treatments. They invest heavily in research, testing, and approvals for safe and effective products. Collaborations help expand their expertise in this fast-growing field.

Cell Based Cartilage Repair/Regeneration Market 2023–2032 (By Therapy Type)

www.custommarketinsight.com

Cell Based Cartilage Repair/Regeneration Market – Regional Analysis

The Cell Based Cartilage Repair/Regeneration Market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region:

  • North America: North America is witnessing a growing trend towards personalized medicine, including cell-based cartilage repair/regeneration therapies tailored to individual patient needs. The region’s strong research infrastructure and investment in clinical trials contribute to the development and commercialization of innovative cell-based treatments. The dominating market players in North America include Vericel Corporation, Zimmer Biomet Holdings, Inc., and Osiris Therapeutics, Inc. (acquired by Smith & Nephew).
  • Europe: Europe’s supportive regulatory landscape for regenerative medicine facilitates the introduction of cell-based cartilage repair/regeneration therapies to the market. Increasing awareness among healthcare professionals and patients about the benefits of cell-based therapies is driving market growth in the region. The dominating market players in Europe include Anika Therapeutics, Inc., BioTissue AG (acquired by Smith & Nephew), and CollPlant Biotechnologies Ltd.
  • Asia-Pacific: Healthcare spending in the Asia-Pacific region is on the rise, which is anticipated to boost the uptake of advanced cell-based therapies for cartilage repair and regeneration. The region’s growing population and rising prevalence of cartilage-related disorders create substantial market potential for cell-based treatments. The dominating market players in the Asia-Pacific region include CellGenix GmbH, Arthrex, Inc., and Histogenics Corporation (acquired by Ocugen, Inc.).
  • LAMEA (Latin America, Middle East, and Africa): Some countries in the LAMEA region are implementing supportive policies and funding initiatives to advance regenerative medicine research, fostering the growth of the market. Improving healthcare infrastructure in certain LAMEA countries is expected to boost the availability and accessibility of cell-based cartilage repair/regeneration therapies. The dominating market players in the LAMEA region include RTI Surgical Holdings, Inc., Smith & Nephew plc, and Medtronic plc.

Cell Based Cartilage Repair/Regeneration Market 2023–2032 (By Mode of Administration)

www.custommarketinsight.com

Competitive Landscape – Cell Based Cartilage Repair/Regeneration Market

The Cell Based Cartilage Repair/Regeneration Market is highly competitive, with a large number of manufacturers and retailers operating globally. Some of the key players in the market include:

  • Vericel Corporation
  • Osiris Therapeutics Inc. (now part of Smith & Nephew)
  • Zimmer Biomet Holdings Inc.
  • Anika Therapeutics Inc.
  • BioTissue AG (now part of Smith & Nephew)
  • Histogenics Corporation (acquired by Ocugen Inc.)
  • RTI Surgical Holdings Inc.
  • Arthrex Inc.
  • CollPlant Biotechnologies Ltd.
  • CellGenix GmbH
  • Others

These companies operate in the market through various strategies such as product innovation, mergers and acquisitions, and partnerships.

New players entering the Cell-Based Cartilage Repair/Regeneration Market are adopting innovation and development to establish their presence. These emerging companies are focusing on advanced cell therapy technologies, exploring novel cell sources, and leveraging cutting-edge tissue engineering methods to offer competitive solutions.

Meanwhile, key players dominating the market, such as Vericel Corporation, Zimmer Biomet Holdings, and Anika Therapeutics, have solidified their position through substantial investment in research, development, and regulatory approvals. Their established market presence, wide product portfolios, and strategic collaborations contribute to their leadership and competitive advantage in meeting the growing demand for effective cartilage repair and regeneration therapies.

The Cell Based Cartilage Repair/Regeneration Market is segmented as follows:

By Therapy Type

  • Autologous Cell Therapy
  • Allogeneic Cell Therapy
  • Others

By Mode of Administration

  • Intra-articular Injection
  • Scaffold Implantation
  • Surgical Implantation

By End Users

  • Hospitals and Clinics
  • Research Institutions and Biotechnology
  • Pharmaceutical Companies

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Cell Based Cartilage Repair/Regeneration Market, (2023 – 2032) (USD Million)
    • 2.2 Global Cell Based Cartilage Repair/Regeneration Market : snapshot
  • Chapter 3. Global Cell Based Cartilage Repair/Regeneration Market – Industry Analysis
    • 3.1 Cell Based Cartilage Repair/Regeneration Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Growing Aging Population
      • 3.2.2 Personalized Medicine
      • 3.2.3 Integration of Digital Health Solutions
      • 3.2.4 Expanding Application Areas
      • 3.2.5 Regulatory Support and Approvals
      • 3.2.6 Public Awareness and Education.
    • 3.3 Market Restraints
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Therapy Type
      • 3.7.2 Market attractiveness analysis By Mode of Administration
      • 3.7.3 Market attractiveness analysis By End Users
  • Chapter 4. Global Cell Based Cartilage Repair/Regeneration Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Cell Based Cartilage Repair/Regeneration Market: company market share, 2022
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Cell Based Cartilage Repair/Regeneration Market – Therapy Type Analysis
    • 5.1 Global Cell Based Cartilage Repair/Regeneration Market overview: By Therapy Type
      • 5.1.1 Global Cell Based Cartilage Repair/Regeneration Market share, By Therapy Type , 2022 and 2032
    • 5.2 Autologous Cell Therapy
      • 5.2.1 Global Cell Based Cartilage Repair/Regeneration Market by Autologous Cell Therapy, 2023 – 2032 (USD Million)
    • 5.3 Allogeneic Cell Therapy
      • 5.3.1 Global Cell Based Cartilage Repair/Regeneration Market by Allogeneic Cell Therapy , 2023 – 2032 (USD Million)
    • 5.4 Others
      • 5.4.1 Global Cell Based Cartilage Repair/Regeneration Market by Others, 2023 – 2032 (USD Million)
  • Chapter 6. Global Cell Based Cartilage Repair/Regeneration Market – Mode of Administration Analysis
    • 6.1 Global Cell Based Cartilage Repair/Regeneration Market overview: By Mode of Administration
      • 6.1.1 Global Cell Based Cartilage Repair/Regeneration Market share, By Mode of Administration , 2022 and 2032
    • 6.2 Intra-articular Injection
      • 6.2.1 Global Cell Based Cartilage Repair/Regeneration Market by Intra-articular Injection, 2023 – 2032 (USD Million)
    • 6.3 Scaffold Implantation
      • 6.3.1 Global Cell Based Cartilage Repair/Regeneration Market by Scaffold Implantation, 2023 – 2032 (USD Million)
    • 6.4 Surgical Implantation
      • 6.4.1 Global Cell Based Cartilage Repair/Regeneration Market by Surgical Implantation, 2023 – 2032 (USD Million)
  • Chapter 7. Global Cell Based Cartilage Repair/Regeneration Market – End Users Analysis
    • 7.1 Global Cell Based Cartilage Repair/Regeneration Market overview: By End Users
      • 7.1.1 Global Cell Based Cartilage Repair/Regeneration Market share, By End Users, 2022 and 2032
    • 7.2 Hospitals and Clinics
      • 7.2.1 Global Cell Based Cartilage Repair/Regeneration Market by Hospitals and Clinics, 2023 – 2032 (USD Million)
    • 7.3 Research Institutions and Biotechnology
      • 7.3.1 Global Cell Based Cartilage Repair/Regeneration Market by Research Institutions and Biotechnology , 2023 – 2032 (USD Million)
    • 7.4 Pharmaceutical Companies
      • 7.4.1 Global Cell Based Cartilage Repair/Regeneration Market by Pharmaceutical Companies, 2023 – 2032 (USD Million)
  • Chapter 8. Cell Based Cartilage Repair/Regeneration Market – Regional Analysis
    • 8.1 Global Cell Based Cartilage Repair/Regeneration Market Regional Overview
    • 8.2 Global Cell Based Cartilage Repair/Regeneration Market Share, by Region, 2022 & 2032 (USD Million)
    • 8.3. North America
      • 8.3.1 North America Cell Based Cartilage Repair/Regeneration Market, 2023 – 2032 (USD Million)
        • 8.3.1.1 North America Cell Based Cartilage Repair/Regeneration Market, by Country, 2023 – 2032 (USD Million)
    • 8.4 North America Cell Based Cartilage Repair/Regeneration Market, by Therapy Type , 2023 – 2032
      • 8.4.1 North America Cell Based Cartilage Repair/Regeneration Market, by Therapy Type , 2023 – 2032 (USD Million)
    • 8.5 North America Cell Based Cartilage Repair/Regeneration Market, by Mode of Administration , 2023 – 2032
      • 8.5.1 North America Cell Based Cartilage Repair/Regeneration Market, by Mode of Administration , 2023 – 2032 (USD Million)
    • 8.6 North America Cell Based Cartilage Repair/Regeneration Market, by End Users, 2023 – 2032
      • 8.6.1 North America Cell Based Cartilage Repair/Regeneration Market, by End Users, 2023 – 2032 (USD Million)
    • 8.7. Europe
      • 8.7.1 Europe Cell Based Cartilage Repair/Regeneration Market, 2023 – 2032 (USD Million)
        • 8.7.1.1 Europe Cell Based Cartilage Repair/Regeneration Market, by Country, 2023 – 2032 (USD Million)
    • 8.8 Europe Cell Based Cartilage Repair/Regeneration Market, by Therapy Type , 2023 – 2032
      • 8.8.1 Europe Cell Based Cartilage Repair/Regeneration Market, by Therapy Type , 2023 – 2032 (USD Million)
    • 8.9 Europe Cell Based Cartilage Repair/Regeneration Market, by Mode of Administration , 2023 – 2032
      • 8.9.1 Europe Cell Based Cartilage Repair/Regeneration Market, by Mode of Administration , 2023 – 2032 (USD Million)
    • 8.10 Europe Cell Based Cartilage Repair/Regeneration Market, by End Users, 2023 – 2032
      • 8.10.1 Europe Cell Based Cartilage Repair/Regeneration Market, by End Users, 2023 – 2032 (USD Million)
    • 8.11. Asia Pacific
      • 8.11.1 Asia Pacific Cell Based Cartilage Repair/Regeneration Market, 2023 – 2032 (USD Million)
        • 8.11.1.1 Asia Pacific Cell Based Cartilage Repair/Regeneration Market, by Country, 2023 – 2032 (USD Million)
    • 8.12 Asia Pacific Cell Based Cartilage Repair/Regeneration Market, by Therapy Type , 2023 – 2032
      • 8.12.1 Asia Pacific Cell Based Cartilage Repair/Regeneration Market, by Therapy Type , 2023 – 2032 (USD Million)
    • 8.13 Asia Pacific Cell Based Cartilage Repair/Regeneration Market, by Mode of Administration , 2023 – 2032
      • 8.13.1 Asia Pacific Cell Based Cartilage Repair/Regeneration Market, by Mode of Administration , 2023 – 2032 (USD Million)
    • 8.14 Asia Pacific Cell Based Cartilage Repair/Regeneration Market, by End Users, 2023 – 2032
      • 8.14.1 Asia Pacific Cell Based Cartilage Repair/Regeneration Market, by End Users, 2023 – 2032 (USD Million)
    • 8.15. Latin America
      • 8.15.1 Latin America Cell Based Cartilage Repair/Regeneration Market, 2023 – 2032 (USD Million)
        • 8.15.1.1 Latin America Cell Based Cartilage Repair/Regeneration Market, by Country, 2023 – 2032 (USD Million)
    • 8.16 Latin America Cell Based Cartilage Repair/Regeneration Market, by Therapy Type , 2023 – 2032
      • 8.16.1 Latin America Cell Based Cartilage Repair/Regeneration Market, by Therapy Type , 2023 – 2032 (USD Million)
    • 8.17 Latin America Cell Based Cartilage Repair/Regeneration Market, by Mode of Administration , 2023 – 2032
      • 8.17.1 Latin America Cell Based Cartilage Repair/Regeneration Market, by Mode of Administration , 2023 – 2032 (USD Million)
    • 8.18 Latin America Cell Based Cartilage Repair/Regeneration Market, by End Users, 2023 – 2032
      • 8.18.1 Latin America Cell Based Cartilage Repair/Regeneration Market, by End Users, 2023 – 2032 (USD Million)
    • 8.19. The Middle-East and Africa
      • 8.19.1 The Middle-East and Africa Cell Based Cartilage Repair/Regeneration Market, 2023 – 2032 (USD Million)
        • 8.19.1.1 The Middle-East and Africa Cell Based Cartilage Repair/Regeneration Market, by Country, 2023 – 2032 (USD Million)
    • 8.20 The Middle-East and Africa Cell Based Cartilage Repair/Regeneration Market, by Therapy Type , 2023 – 2032
      • 8.20.1 The Middle-East and Africa Cell Based Cartilage Repair/Regeneration Market, by Therapy Type , 2023 – 2032 (USD Million)
    • 8.21 The Middle-East and Africa Cell Based Cartilage Repair/Regeneration Market, by Mode of Administration , 2023 – 2032
      • 8.21.1 The Middle-East and Africa Cell Based Cartilage Repair/Regeneration Market, by Mode of Administration , 2023 – 2032 (USD Million)
    • 8.22 The Middle-East and Africa Cell Based Cartilage Repair/Regeneration Market, by End Users, 2023 – 2032
      • 8.22.1 The Middle-East and Africa Cell Based Cartilage Repair/Regeneration Market, by End Users, 2023 – 2032 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1 Vericel Corporation
      • 9.1.1 Overview
      • 9.1.2 Financials
      • 9.1.3 Product Portfolio
      • 9.1.4 Business Strategy
      • 9.1.5 Recent Developments
    • 9.2 Osiris Therapeutics Inc. (now part of Smith & Nephew)
      • 9.2.1 Overview
      • 9.2.2 Financials
      • 9.2.3 Product Portfolio
      • 9.2.4 Business Strategy
      • 9.2.5 Recent Developments
    • 9.3 Zimmer Biomet Holdings Inc.
      • 9.3.1 Overview
      • 9.3.2 Financials
      • 9.3.3 Product Portfolio
      • 9.3.4 Business Strategy
      • 9.3.5 Recent Developments
    • 9.4 Anika Therapeutics Inc.
      • 9.4.1 Overview
      • 9.4.2 Financials
      • 9.4.3 Product Portfolio
      • 9.4.4 Business Strategy
      • 9.4.5 Recent Developments
    • 9.5 BioTissue AG (now part of Smith & Nephew)
      • 9.5.1 Overview
      • 9.5.2 Financials
      • 9.5.3 Product Portfolio
      • 9.5.4 Business Strategy
      • 9.5.5 Recent Developments
    • 9.6 Histogenics Corporation (acquired by Ocugen Inc.)
      • 9.6.1 Overview
      • 9.6.2 Financials
      • 9.6.3 Product Portfolio
      • 9.6.4 Business Strategy
      • 9.6.5 Recent Developments
    • 9.7 RTI Surgical Holdings Inc.
      • 9.7.1 Overview
      • 9.7.2 Financials
      • 9.7.3 Product Portfolio
      • 9.7.4 Business Strategy
      • 9.7.5 Recent Developments
    • 9.8 Arthrex Inc.
      • 9.8.1 Overview
      • 9.8.2 Financials
      • 9.8.3 Product Portfolio
      • 9.8.4 Business Strategy
      • 9.8.5 Recent Developments
    • 9.9 CollPlant Biotechnologies Ltd.
      • 9.9.1 Overview
      • 9.9.2 Financials
      • 9.9.3 Product Portfolio
      • 9.9.4 Business Strategy
      • 9.9.5 Recent Developments
    • 9.10 CellGenix GmbH
      • 9.10.1 Overview
      • 9.10.2 Financials
      • 9.10.3 Product Portfolio
      • 9.10.4 Business Strategy
      • 9.10.5 Recent Developments
    • 9.11 Others.
      • 9.11.1 Overview
      • 9.11.2 Financials
      • 9.11.3 Product Portfolio
      • 9.11.4 Business Strategy
      • 9.11.5 Recent Developments
List Of Figures

Figures No 1 to 25

List Of Tables

Tables No 1 to 77

Report Methodology

In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:

Preliminary Data Mining

On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.

Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.

Statistical Model

Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.

Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.

Some of the variables taken into account for forecasting are as follows:

• Industry drivers and constraints, as well as their current and projected impact

• The raw material case, as well as supply-versus-price trends

• Current volume and projected volume growth through 2030

We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.

Primary Validation

This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.

Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.

All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:

• Market leaders

• Suppliers of raw materials

• Suppliers of raw materials

• Buyers.

The following are the primary research objectives:

• To ensure the accuracy and acceptability of our data.

• Gaining an understanding of the current market and future projections.

Data Collection Matrix

Perspective Primary research Secondary research
Supply-side
  • Manufacturers
  • Technology distributors and wholesalers
  • Company reports and publications
  • Government publications
  • Independent investigations
  • Economic and demographic data
Demand-side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customers


Market Analysis Matrix

Qualitative analysis Quantitative analysis
  • Industry landscape and trends
  • Market dynamics and key issues
  • Technology landscape
  • Market opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2030
  • Market revenue estimates and forecasts up to 2030, by technology
  • Market revenue estimates and forecasts up to 2030, by application
  • Market revenue estimates and forecasts up to 2030, by type
  • Market revenue estimates and forecasts up to 2030, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Prominent Player

  • Vericel Corporation
  • Osiris Therapeutics Inc. (now part of Smith & Nephew)
  • Zimmer Biomet Holdings Inc.
  • Anika Therapeutics Inc.
  • BioTissue AG (now part of Smith & Nephew)
  • Histogenics Corporation (acquired by Ocugen Inc.)
  • RTI Surgical Holdings Inc.
  • Arthrex Inc.
  • CollPlant Biotechnologies Ltd.
  • CellGenix GmbH
  • Others

FAQs

The key factors driving the Market are Growing Aging Population, Personalized Medicine, Integration of Digital Health Solutions, Expanding Application Areas, Regulatory Support and Approvals And Public Awareness and Education.

The “Therapy Type” category dominated the market in 2022.

The key players in the market are Vericel Corporation, Osiris Therapeutics Inc. (now part of Smith & Nephew), Zimmer Biomet Holdings Inc., Anika Therapeutics Inc., BioTissue AG (now part of Smith & Nephew), Histogenics Corporation (acquired by Ocugen Inc.), RTI Surgical Holdings Inc., Arthrex Inc., CollPlant Biotechnologies Ltd., CellGenix GmbH, Others.

“Europe” had the largest share in the Cell Based Cartilage Repair/Regeneration Market.

The global market is projected to grow at a CAGR of 5.3% during the forecast period, 2023-2032.

The Cell Based Cartilage Repair/Regeneration Market size was valued at USD 675.4 Million in 2022.

PURCHASE OPTIONS

$

3490


$

4490


$

5490


$

1950


powerbi pdf
$

6200

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • Free 25% or 40 hours of customisation.
  • Free post-sale service assistance.
  • 15% discount on your next purchase.
  • Dedicated account Associate .
  • Permission to print the report.
  • Service guarantee available.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • Free 35% or 60 hours of customisation.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantee available.
  • Personalised market brief by author.
  • Permission to print the report.
  • PDF, Excel and Power Point.
  • Can be accessible by unlimited users.
  • Free 40% or 80 hours of customisation.
  • Free post-sale service assistance.
  • 30% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account manager.
  • Service guarantee available.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
  • 15% discount on your next purchase.
  • Free 20% or 10 hours of customisation.
  • PDF, Excel, Power Point and Power BI.
  • Every Year Free Update ( Apr – Apr)
  • Personalized market brief by author
  • Can be accessible by unlimited users.
  • Free 50% or 90 hours of customization.
  • Up to 50 Company Profiles
  • Free post-sale service assistance with guarantee
  • 40% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account team.
  • Service guarantee available.

Want to customize this report?
100% FREE CUSTOMIZATION!